UBS Group’s BiomX Inc. Warrants to purchase one-half of a share of Common Stock PHGE.WS Stock Holding History

UBS Group’s Portfolio PHGE.WS Stock Details PHGE.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10	Closed	–	–	10298
2023 Q1	$0	Sell	10 -52,423	-100%	-$1.05K	﹤0.01%	11154
2022 Q4	$1.05K	Sell	52,433 -2,224	-4%	-$51	﹤0.01%	9972
2022 Q3	$2K	Buy	54,657 +3,100	+6%	+$128	﹤0.01%	9860
2022 Q2	$2K	Buy	51,557 +1,183	+2%	+$130	﹤0.01%	9721
2022 Q1	$7K	Buy	+50,374	New	+$5.95K	﹤0.01%	8896
2021 Q3	–	Sell	-2,065	Closed	-$1K	–	10384
2021 Q2	$1K	Sell	2,065 -1,237	-37%	-$791	﹤0.01%	9247
2021 Q1	$2K	Buy	+3,302	New	+$2.44K	﹤0.01%	8680
2020 Q2	–	Sell	-65	Closed	–	–	8504
2020 Q1	$0	Sell	65 -435	-87%	-$375	﹤0.01%	8571
2019 Q4	$0	Buy	+500	New	+$312	﹤0.01%	8530

Other funds holding PHGE.WS

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group's PHGE.WS Position: Q2 2023 in Review

UBS Group sold out of BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) in Q2 2023, closing a stake of 10 shares.

UBS Group first reported a position in PHGE.WS in Q4 2019 and held it in 9 quarters. The position peaked at $7K in Q1 2022. 1 fund tracked by Wall St. Rank holds PHGE.WS as of Q2 2023.

UBS Group reported no remaining BiomX Inc. Warrants to purchase one-half of a share of Common Stock position as of Q2 2023 after selling out during the quarter.
UBS Group sold 10 BiomX Inc. Warrants to purchase one-half of a share of Common Stock shares in Q2 2023.
UBS Group first reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in Q4 2019 and held it in 9 quarters.
UBS Group's BiomX Inc. Warrants to purchase one-half of a share of Common Stock position peaked at $7K in Q1 2022.
1 fund tracked by Wall St. Rank held BiomX Inc. Warrants to purchase one-half of a share of Common Stock as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.